ArticleDiscover oncology2025
Causal effects of circulating inflammatory proteins on colorectal cancer: a Mendelian randomization and Spatial transcriptomic study.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to investigate the potential causal relationships between 91 circulating inflammatory proteins and colorectal cancer (CRC) using a two-sample bidirectional Mendelian randomization (MR) framework, supplemented by spatial transcriptomic analysis.
methodsGenetic instruments for circulating inflammatory proteins were obtained from genome-wide association studies (GWAS) involving individuals of European ancestry. CRC outcome data were sourced from BioBank Japan. The inverse variance weighted (IVW) method was used as the primary analytical approach, complemented by MR-Egger regression, weighted median, and mode-based estimators. Horizontal pleiotropy and heterogeneity were assessed using the MR-Egger intercept, Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO) test, and Cochran's Q statistic. The Mendelian randomization Steiger (MR-Steiger) method was employed to verify causal directionality. Spatial transcriptomic profiling of CRC tissue was performed to evaluate the spatial expression patterns and cell-type-specific co-expression profiles of MR-identified candidate genes.
resultsThree inflammatory proteins demonstrated significant associations with CRC risk. Tumor necrosis factor receptor superfamily member 9 (TNFRSF9) and interleukin-20 receptor subunit alpha (IL20RA) were positively associated with increased risk, whereas latency-associated peptide transforming growth factor beta 1 (LAP-TGF-β1) showed a protective association. These associations remained robust across all sensitivity analyses. Spatial transcriptomic analysis revealed that TNFRSF9 expression was enriched in immune cell-dense stromal regions, while IL20RA was predominantly expressed in tumor cell-dominated areas, indicating distinct cellular mechanisms.
conclusionThis integrative study provides genetic and spatial evidence supporting the involvement of specific circulating inflammatory proteins in colorectal carcinogenesis. TNFRSF9 and IL20RA may act as pro-tumorigenic mediators, while LAP-TGF-β1 may confer protective effects. These findings offer new insights into inflammation-related CRC pathogenesis and may inform future biomarker or therapeutic targetd evelopment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.